Screening for cervical neoplasia by self-assessment for human papillomavirus DNA.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 10622304.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We evaluated self-collected vaginal human papillomavirus tests for cervical cancer screening and compared it with the specimens taken directly from the cervix in 247 patients at high-risk for cervical disease. The sample taken by the patient showed human papillomavirus DNA in a higher percentage than the sample taken by a doctor. Sensitivity of high-risk human papillomavirus types for high-grade cervical precursors (CIN 2/3) and invasive cervical cancers were 93% for both methods.
Medical subject headings
- DNA, Viral
- Mass Screening
- Papillomaviridae
- Uterine Cervical Neoplasms
- Vaginal Smears